An AAV vaccine targeting the RBD of the SARS-CoV-2 S protein induces effective neutralizing antibody titers in mice and canines

The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has resulted in catastrophic damage worldwide. Accordingly, the development of powerful, safe, easily accessible vaccines with long-term effectiveness is understood as an urgently...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fei, Feng, Canbin, Xu, Shiqi, Wu, Qiang, Tang, Jian, Chen, Yan, Xu, Ruisheng, Chen, Fuliang, Gao, Ni, Xu, Zhengzheng, Gu, Shihui, Lan, Yang, Zhou, Haibo, Hu, Xinde, Wang, Xiaojing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769940/
https://www.ncbi.nlm.nih.gov/pubmed/35094871
http://dx.doi.org/10.1016/j.vaccine.2022.01.030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769940/
https://www.ncbi.nlm.nih.gov/pubmed/35094871
http://dx.doi.org/10.1016/j.vaccine.2022.01.030

Ejemplares similares